Catalyst Wire Dossier Catalyst Wire Dossier

Ceftolozane/Tazobactam

ceftolozane/tazobactam · Merck & Co.
Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for Ceftolozane/Tazobactam, covering 2015-06-15 to 2025-05-02. Get the full timeline:

Most recent: Clinical Trial Update: Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase - Producing Pathogens [Phase 4]

See pricing